1-3 of 3
Stephanie Valer Seremetis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mim8 Clinical Development Program: An Overview of the Frontier Studies

Stephanie Valer Seremetis, Wan Hui Ong Clausen, Irina Matytsina, Susanne Møller Nissen, Karin Wåhlander
Journal: Blood
Blood (2022) 140 (Supplement 1): 5630–5631.
https://doi.org/10.1182/blood-2022-163554
Published: 2022
Journal Articles

Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events

Stephanie Valer Seremetis, MD, Katarina Cepo, MD, Josephine Skovgaard Rasmussen, DVM, Trine Høyer Rose, PhD, Søren Tamer, MSc, Thomas Porstmann, PhD, Jesper Haaning, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40.
https://doi.org/10.1182/blood-2020-139563
Published: 2020
Journal Articles

Beyond ABR: High FIX Activity Levels Translate into Clinical Benefits over Standard Prophylaxis

Guy Young, Manuel Carcao, MDMSc, Susan Kearney, MD, Stephanie Valer Seremetis, MD, David L Cooper, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2372.
https://doi.org/10.1182/blood.V130.Suppl_1.2372.2372
Published: 2017